ArticleJCI insight2022
Epigenetic drug screening defines a PRMT5 inhibitor-sensitive pancreatic cancer subtype.
Felix Orben et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this papercites it
ArticleJCI insight2022
Felix Orben et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.